Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

被引：104
|
作者：
Blom, Dirk J. [1 ]
Averna, Maurizio R. [2 ]
Meagher, Emma A. [3 ]
Theron, Hendrik du Toit [4 ]
Sirtori, Cesare R.
Hegele, Robert A. [5 ,6 ]
Shah, Prediman K. [7 ]
Gaudet, Daniel [8 ]
Stefanutti, Claudia [9 ]
Vigna, Giovanni B. [10 ]
Larrey, Dominique [11 ]
Bloedon, LeAnne T. [12 ]
Foulds, Pamela [12 ]
Rader, Daniel J. [3 ]
Cuchel, Marina [3 ]
机构：
[1] Univ Cape Town, Cape Town, South Africa
[2] Univ Palermo, Palermo, Italy
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Netcare Private Hosp, Bloemfontein, South Africa
[5] Osped Niguarda Ca Granda, Milan, Italy
[6] Univ Western Ontario, London, ON, Canada
[7] Cedars Sinai Heart Inst, Los Angeles, CA USA
[8] Univ Montreal, Chicoutimi, PQ, Canada
[9] Univ Roma Sapienza, Rome, Italy
[10] Univ Ferrara, Ferrara, Italy
[11] CHRU Montpellier, Montpellier, France
[12] Aeger Pharmaceut, Cambridge, MA USA
来源：
CIRCULATION | 2017年 / 136卷 / 03期
关键词：
lomitapide;
D O I：
10.1161/CIRCULATIONAHA.117.028208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：332 / 335
页数：4
相关论文
共 50 条
  • [21] Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)
    Underberg, James A.
    Cannon, Christopher P.
    Larrey, Dominique
    Makris, Lukas
    Blom, Dirk
    Phillips, Helen
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (06) : 807 - 817
  • [22] POTENTIAL EFFICACY OF LOMITAPIDE, A MTP (MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN) INHIBITOR, ON SURVIVAL IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA (HOFH): RESULTS OF AN EVENT MODELLING ANALYSIS
    Leipold, R.
    Raal, F.
    Ishak, J.
    Phillips, H.
    Deanfield, J.
    VALUE IN HEALTH, 2016, 19 (07) : A373 - A374
  • [23] Long-Term Efficacy and Safety of Evinacumab in Adult and Adolescent Patients With Homozygous Familial Hypercholesterolemia
    Gaudet, Daniel
    Saheb, Samir
    Iannuzzo, Gabriella
    Stefanutti, Claudia
    Stroes, Erik S.
    Rosenson, Robert S.
    Turner, Traci
    Ali, Shazia
    Banerjee, Poulabi
    Drewery, Tiera
    Pordy, Robert
    Zhao, Jian
    Raal, Frederick J.
    CIRCULATION, 2021, 144
  • [24] LONG-TERM EFFECTIVENESS AND SAFETY OF LOMITAPIDE: REAL-WORLD EXPERIENCE FROM ITALY IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Suppressa, P.
    Coppola, C.
    Cocco, V.
    O'Brien, S.
    Stanzione, C.
    De Ruberto, F.
    Lannuzzo, G.
    ATHEROSCLEROSIS, 2023, 379
  • [25] LONG-TERM LIVER SAFETY OF LOMITAPIDE IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THREE-YEAR DATA FROM LOWER
    Larrey, Dominique
    Underberg, James
    Cannon, Christopher P.
    Makris, Lukas
    Jurecka, Agnieszka
    Blom, Dirk
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 153 - 153
  • [26] Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia
    Walsh, Meghan T.
    Hussain, M. Mahmood
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2017, 54 (01) : 26 - 48
  • [27] Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia
    Cegla, J.
    Larrey, D.
    D'Erasmo, L.
    O'Brien, S.
    Arca, M.
    ATHEROSCLEROSIS PLUS, 2023, 54 : S2 - S3
  • [28] PHASE 3 STUDY OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR (MTP-I) LOMITAPIDE IN SUBJECTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): 56-WEEK RESULTS
    Cuchel, M.
    Meagher, E.
    Marais, A. D.
    Blom, D. J.
    Theron, H. du Toit
    Shah, P. K.
    Hegele, R. A.
    Bloeden, L. T.
    Sasiela, W. J.
    Rader, D. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 14 - 14
  • [29] Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
    Cuchel, Marina
    Bloedon, LeAnne T.
    Szapary, Philippe O.
    Kolansky, Daniel M.
    Wolfe, Megan L.
    Sarkis, Antoine
    Millar, John S.
    Ikewaki, Katsunori
    Siegelman, Evan S.
    Gregg, Richard E.
    Rader, Daniel J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02): : 148 - 156
  • [30] Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study
    Nohara, Atsushi
    Otsubo, Yoshihiko
    Yanagi, Koji
    Yoshida, Masayuki
    Ikewaki, Katsunori
    Harada-Shiba, Mariko
    Jurecka, Agnieszka
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2019, 26 (04) : 368 - 377
12345